Next month the FDA is hosting a public advisory committee meeting to discuss a change to the intended use of Dexcom's G5 Mobile Continuous Glucose Monitoring System (CGM) device that would allow the ...
LONDON--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...
Add Yahoo as a preferred source to see more of our stories on Google. May 26 (Reuters) - Medical device maker Dexcom said on Tuesday some of its glucose ‌sensors slated for destruction were instead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results